Figure 4
From: Blockade of SARS-CoV-2 spike protein-mediated cell–cell fusion using COVID-19 convalescent plasma
Inhibition of SARS-CoV-2 infection by COVID-19 convalescent plasma. (a) Representative fluorescent images showing inhibition of SARS-CoV-2 infection by convalescent patient's plasma. Negative and positive controls of PsV infection into 293 T/ACE2 target cells are shown. (b) Neutralization assays showing that COVID-19 convalescent plasma inhibits SARS-CoV-2 S PsV infection. (c) The dilution factors of patient plasma and their corresponding concentrations of anti-S1 IgG antibodies are shown. The graph in b was created by Prism 6.01 software (https://www.graphpad.com/).
